|
|
| | ANTI-HTNF RECEPTOR-ASSOCIATED FACTOR 2 (TRAF 2) Basic information |
| Product Name: | ANTI-HTNF RECEPTOR-ASSOCIATED FACTOR 2 (TRAF 2) | | Synonyms: | ANTI-TNF RECEPTOR-ASSOCIATED FACTOR2 (HUMAN);ANTI-TRAF2;ANTI-TRAF2 (HUMAN);ANTI-TUMOR NECROSIS FACTOR2 (HUMAN);ANTI-TUMOR NECROSIS FACTOR RECEPTOR ASSOC FACTOR 2;ANTI-HTNF RECEPTOR-ASSOCIATED FACTOR 2 (TRAF 2);ANTI-HUMAN TRAF-2;ANTI-HUMAN TNF RECEPTOR ASSOCIATED FACTOR2 | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![ANTI-HTNF RECEPTOR-ASSOCIATED FACTOR 2 (TRAF 2) Structure]() |
| | ANTI-HTNF RECEPTOR-ASSOCIATED FACTOR 2 (TRAF 2) Chemical Properties |
| | ANTI-HTNF RECEPTOR-ASSOCIATED FACTOR 2 (TRAF 2) Usage And Synthesis |
| General Description | The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from members of the TNF receptor superfamily. This protein directly interacts with TNF receptors, and forms a heterodimeric complex with TRAF1. This protein is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF1 interacts with the inhibitor-of-apoptosis proteins (IAPs), and functions as a mediator of the anti-apoptotic signals from TNF receptors. The interaction of this protein with TRADD, a TNF receptor associated apoptotic signal transducer, ensures the recruitment of IAPs for the direct inhibition of caspase activation. BIRC2/c-IAP1, an apoptosis inhibitor possessing ubiquitin ligase activity, can unbiquitinate and induce the degradation of this protein, and thus potentiate TNF-induced apoptosis. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of only one transcript has been determined. (provided by RefSeq) |
| | ANTI-HTNF RECEPTOR-ASSOCIATED FACTOR 2 (TRAF 2) Preparation Products And Raw materials |
|